Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examples

With the development of ever more radiopharmaceuticals suitable for theranostic applications, translation of novel compounds from the preclinical stage towards clinical application becomes a bottleneck for the advances in Nuclear Medicine. This review article summarizes the current regulatory framew...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolenc Peitl, Petra, Rangger, Christine, Garnuszek, Piotr, Mikolajczak, Renata, Hubalewska‐Dydejczyk, Alicja, Maina, Theodosia, Erba, Paola, Decristoforo, Clemens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Special Issue Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767129/
https://www.ncbi.nlm.nih.gov/pubmed/30741441
http://dx.doi.org/10.1002/jlcr.3712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767129/
https://www.ncbi.nlm.nih.gov/pubmed/30741441
http://dx.doi.org/10.1002/jlcr.3712

Ejemplares similares